Long-Term Benefit in HF Patients Elusive for Novel Vasodilator

ACC Conference Reporter

AHA 2016 | NEW ORLEANS — Short term vasodilator treatment for acute heart failure in the hospital did not lead to long term clinical benefits in the largest and most rigorous trial in the field yet performed, researchers said. Read More >>>

Keywords: AHA Annual Scientific Sessions, AHA16


< Back to Listings